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Abstract
Background: We describe the identification of, and risk factors for, the single most prevalent Mycobacterium tuberculosis
strain in the West Midlands region of the UK.
Methodology/Principal Findings: Prospective 15-locus MIRU-VNTR genotyping of all M. tuberculosis isolates in the West
Midlands between 2004 and 2008 was undertaken. Two retrospective epidemiological investigations were also undertaken
using univariable and multivariable logistic regression analysis. The first study of all TB patients in the West Midlands
between 2004 and 2008 identified a single prevalent strain in each of the study years (total 155/3,056 (5%) isolates). This
prevalent MIRU-VNTR profile (32333 2432515314 434443183) remained clustered after typing with an additional 9-loci
MIRU-VNTR and spoligotyping. The majority of these patients (122/155, 79%) resided in three major cities located within a
40 km radius. From the apparent geographical restriction, we have named this the ‘‘Mercian’’ strain. A multivariate analysis
of all TB patients in the West Midlands identified that infection with a Mercian strain was significantly associated with being
UK-born (OR=9.03, 95%CI=4.56–17.87, p,0.01), Black Caribbean (OR=5.68, 95%CI=2.96–10.91, p,0.01) resident in
Wolverhampton (OR=9.29, 95%CI=5.69–15.19, p,0.01) and negatively associated with age .65 years old (OR=0.25,
95%CI=0.09–0.67, p,0.01). A second more detailed investigation analyzed a cohort of 82 patients resident in
Wolverhampton between 2003 and 2006. A significant association with being born in the UK remained after a multivariate
analysis (OR=9.68, 95%CI=2.00–46.78, p,0.01) and excess alcohol intake and cannabis use (OR=6.26, 95%CI=1.45–27.02,
p=.01) were observed as social risk factors for infection.
Conclusions/Significance: The continued consistent presence of the Mercian strain suggests ongoing community
transmission. Whilst significant associations have been found, there may be other common risk factors yet to be identified.
Future investigations should focus on targeting the relevant risk groups and elucidating the biological factors that mediate
continued transmission of this strain.
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Introduction
DNA fingerprinting of Mycobacterium tuberculosis has a key role in
TB control and cluster investigation as the molecular data
obtained can be used to direct and focus public health control
efforts [1,2]. For example, DNA fingerprinting enhanced the
investigation of a large outbreak in North London where many of
the epidemiological links would not have been established by
routine contact tracing or traditional epidemiological investiga-
tions alone [3]. Large-scale studies of M. tuberculosis strains have
also enabled the assessment of the impact of global strain
migration and the transmission dynamics of specific strains on a
local or regional level [4–8].
The number of cases of tuberculosis in the UK has consistently
increased each year since the late 1980s with 8,655 cases (14.1
cases per 100,000 population) diagnosed in 2008. There were
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e179301,012 clinical cases (18.7 per 100,000) in the West Midlands
region of the UK with a 43% increase in case numbers in the
region since 2000. Birmingham is the largest city in the West
Midlands with a rate of 42.4 cases per 100,000 in 2008. There
were 44.3 cases per 100,000 in London in 2008. There is large
variation in the incidence of TB across the West Midlands, with
rates highest in one urban area of Birmingham (.80 cases per
100,000) and lowest in rural Worcestershire (,4 cases per
100,000 in 2008) [9].
We analyzed all M. tuberculosis isolates in the West Midlands
region of the UK from 2004 and 2008 by universal prospective
DNA fingerprinting and identified the most prevalent strain.
We then examined the geographical distribution and epidemi-
ological characteristics of cases infected with this strain in
the West Midlands region, and in the city of Wolverhampton,
which was found to have the highest proportion of patients
with this strain.
Methods
Study Population
The setting for this study was the West Midlands region of the
UK. This region had a total population of 5.4 million in 2008. The
city of Birmingham has the largest population in the West
Midlands with one million inhabitants [10]. Prospective universal
DNA fingerprinting was undertaken between 2004 and 2008 with
retrospective genotyping carried out on strains isolated before
2004. Retrospective observational epidemiological investigations
were undertaken within one city and on a regional scale.
Case definition
Patients with the MIRU-VNTR profile of the most prevalent
M. tuberculosis strain in the West Midlands were included in further
epidemiological investigation.
Mycobacterial strains and DNA fingerprinting
The HPA Midlands Regional Centre for Mycobacteriology
undertook IS6110 Restriction Fragment Length Polymorphism
(RFLP) typing on specific requested M. tuberculosis strains until
2004. From 2004 onwards, all M. tuberculosis isolates received
from laboratories in the West and East Midlands at the HPA
Midlands Regional Centre for Mycobacteriology at Birmingham
Heartlands Hospital identified as members of the M. tuberculosis
complex were analysed by MIRU-VNTR (Mycobacterial
Interspersed Repetitive Units containing Variable Number
Tandem Repeats) typing using 15 loci as previously described
(ETR-A, -B, -C, -D, -E and MIRU-02, -10, -16, -20, -23, -24,
-26, -27, -39, -40) [1,11,12]. The most recent complete
calendar year available for molecular and epidemiological
data analysis was 2008. A selection of strains were analysed by
nine additional loci (Mtub04, Mtub21, QUB-11b, Mtub29,
Mtub30, Mtub34, Mtub39, QUB-26, QUB-4156) that together
with the 15 loci comprise the internationally optimised set of
24 loci [13].
M. tuberculosis strain clustering analysis
MIRU-VNTR and IS6110 RFLP data were entered into
BioNumerics v5.1 (Applied Maths, Saint Marten-Latem, Bel-
gium) to identify clustered MIRU-VNTR profiles. MIRU-VNTR
data was queried against the HPA UK Mycobacterium tuberculosis
Strain Typing Database which contains 26,879 typed M.
tuberculosis strains from six contributing centres in the United
Kingdom [14].
Confirmation of the most prevalent MIRU-VNTR profile as
a single strain by IS6110 RFLP
For M. tuberculosis isolates originally cultured between 1995 and
2003, DNA fingerprinting was undertaken retrospectively on
requested clusters with significant epidemiological links. Strains
were retrospectively analyzed by MIRU-VNTR and IS6110
RFLP typing to confirm the genetic relatedness within clusters.
IS6110 RFLP interrogates a different and independent genetic
sequence than MIRU-VNTR typing. IS6110 RFLP was under-
taken in accordance with the international standardized protocol
using M. tuberculosis strain MT14323 as a control strain [15].
Assignation of global clade lineage
Spoligotyping was carried out to identify the global strain family
that the most prevalent strain is part of. Spoligotyping was
performed using the Luminex Multianalyte Profiling System as
previously described [16]. Spoligotype families were assigned by
comparison to the international SpolDB4 database [17].
West Midlands regional epidemiological analysis
Patients with M. tuberculosis strains identified as the Mercian
strain between 2004 and 2008 were compared to all patients with
tuberculosis in the West Midlands between 2004 and 2008 in the
HPA Enhanced Tuberculosis Surveillance System. The HPA
Enhanced Tuberculosis Surveillance System contains molecular,
pathological, and treatment data on all notified cases of
tuberculosis in England including culture-confirmed cases and
clinically diagnosed cases. All patients with strain typing data were
selected for comparison. Two levels of patient residence were
analyzed: West Midlands Health Protection Unit and Local
Authority. Local HPA Health Protection Units work alongside the
National Health Service in England providing specialist support in
communicable disease and infection control. There are three
Health Protection Units in the West Midlands: West Midlands
East, West Midlands North, and West Midlands West. The major
cities of Birmingham and Coventry are located in West Midlands
East, Stoke-on-Trent in West Midlands North, and Wolverhamp-
ton in West Midlands West. More specific analysis of patient
residence was undertaken by analyzing patient location within one
of 33 Local Authority regions in the West Midlands. Local
Authorities are administrative regions that are based on city or
county boundaries.
Geographical distribution of the Mercian strain within
the West Midlands region
Laboratory records of patients with the most prevalent strain
were used to map patient residential location using postcode
within the West Midlands.
City specific epidemiological investigation
When it became apparent that there was a cohort of patients in
Wolverhampton with an indistinguishable MIRU-VNTR profile,
a retrospective review of patient case notes and interview of
specialist tuberculosis nurses who were involved with the care of
these patients was undertaken for culture-positive patients resident
in Wolverhampton diagnosed with the same indistinguishable
MIRU-VNTR profile between June 2003 and February 2006 to
identify common factors and potential epidemiological links.
These patients were compared to culture-positive cases diagnosed
with other strains in 2004.
A questionnaire was designed to collect comprehensive
epidemiologic information including demographic characteristics,
clinical history, predisposing risk factors and evidence of contact
TB in the Midlands, UK
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was also obtained on occupational, social and recreational history,
compliance with tuberculosis treatment and change in weight after
eight weeks treatment. Chest radiographs of all patients were
reviewed for the presence of cavitation.
Statistical analysis
Proportions calculated from epidemiological data obtained from
the West Midlands regional and Wolverhampton city datasets
were compared using Pearson’s chi-squared test with Fisher’s exact
test where necessary. Univariate and multivariate logistic regres-
sion modeling was used to test the significance of odds ratios in
Stata v10 (Stata Corp, College Station, TX, USA). The
multivariable model was assembled by adding covariates individ-
ually in decreasing order of significance and the ‘‘goodness of fit’’
of each model was assessed using the likelihood ratio test. All cases
with missing values for the variables examined were excluded from
the multivariate model with 114 patients infected by the Mercian
strain and 1,891 patients in the control group included.
Differences in proportions between entries with complete data
for each variable and missing data for at least one variable was
analysed. A univariate analysis of the epidemiological investigation
of patients resident in Wolverhampton was undertaken using
EpiData Analysis v2.2 (EpiData Association, Odense, Denmark).
The extent of any association was expressed as an odds ratio (OR)
with 95% confidence intervals.
Ethics Statement
This report details the current status of the investigation into the
most prevalent strain in the West Midlands, which has been
undertaken as part of normal public health practice by
microbiologists, respiratory physicians, and public health teams.
Therefore, specific ethical approval was not required. The Health
Protection Agency (HPA) has Patient Information Advisory Group
permission under the Health and Social Care Act 2001 to collect
and analyse such data for public health purposes.
Results
M. tuberculosis strains
Between 2004 and 2008, 4,830 isolates were typed from 31
referring laboratories in the West and East Midlands. Duplicate
isolates (n=171) were removed so that 4,659 isolates representing
the first typed isolate from each patient between 1
stJanuary 2004
and 31
st December 2008 were selected. From 4,659 isolates typed,
3,056/4,659 (66%) originated from patients resident in the West
Midlands and 1,603/4,659 (34%) from patients resident in the
East Midlands. The single most prevalent MIRU-VNTR profile
was 32333 2432515314, which was identified in 156/4,659 (3%)
isolates across the West and East Midlands and 155/3,056 (5%)
isolates in the West Midlands. Only one strain with this MIRU-
VNTR profile was identified in the East Midlands. This profile
was identified soon after universal prospective DNA fingerprinting
was initiated in 2004 and has been consistently identified since
then (Figure 1). The second and third most prevalent profiles were
42235 2542517333 (117/4,659, 3%) and 42235 2642515333 (88/
4,659, 2%).
Case definition
Inclusion of a patient for further epidemiological investigation
was based on MIRU-VNTR typing, with a confirmed case defined
as a patient with microbiologically confirmed tuberculosis and an
isolate that had the 32333 2432515314 MIRU-VNTR profile.
UK distribution of the most prevalent MIRU-VNTR profile
in the West Midlands
The HPA UK Mycobacterium tuberculosis Strain Typing Database
was interrogated to analyze the national distribution of the most
prevalent strain in the West Midlands with a total of 176 isolates
identified across the UK between 2004 and 2008. Only 6/162
(4%) of these isolates were identified in patients resident outside of
the Midlands. Since this MIRU-VNTR profile appeared to be
geographically restricted to the West Midlands in the UK, we have
named the profile the ‘‘Mercian strain’’, after the Anglo-Saxon
kingdom of Mercia [18].
Geographical distribution of the Mercian strain within
the West Midlands region
Three major cities in the West Midlands were the focus for this
strain as 55/156 (35%) isolates originated from Wolverhampton,
41/156 (26%) isolates from Birmingham, and 26/156 (17%)
isolates from Coventry. Overall, 122/156 (78%) Mercian isolates
were identified in patients resident in one of these three cities
which are located within a 40 km radius of each other. The
Mercian strain accounted for 21% (53/258) of all M. tuberculosis
isolates in Wolverhampton compared to 9% (27/285) of all strains
in Coventry and 3% (41/1,243) in Birmingham. Figure 2 shows
the geographical mapping of 32333 2432515314 in the West
Midlands between 2004 and 2008.
Confirmation of the 32333 2432515314 MIRU-VNTR
profile as a distinct strain
Retrospective typing of stored M. tuberculosis isolates resulted in
the identification of an additional 51 isolates from six different
locations as members of the 32333 2432515314 Mercian strain
MIRU-VNTR profile. Upon further investigation by IS6110
RFLP, 50/51 (98%) of these strains were still indistinguishable
(Figure 3) with a 7-band RFLP pattern. One isolate from
Wolverhampton in 2003 possessed 8 copies of IS6110 but this
can still be considered as part of the same strain and the MIRU-
VNTR profile did not vary in this single isolate. A selection of 10
strains from five different locations isolated between 2004 and
2008 were analyzed by the optimal 24 MIRU-VNTR loci set
and spoligotyping. All 10 strains were indistinguishable at each
of the 24 loci (32333 2432515314 434443183) and possessed an
indistinguishable spoligotype (octal type 767776777760771)
which is shared type (ST) 490 and is a member of the Clade
X1 global clade. Investigation of the global SpolDB4 database
revealed that only 3 strains with this shared type have been
identified. The 3 other strains that are members of ST490 were
identified as single strains in London, New York and Washing-
ton, DC.
West Midlands regional epidemiological analysis
A total of 124/156 (79%) tuberculosis patients with the Mercian
strain were successfully matched to notification data in the HPA
Enhanced Tuberculosis Surveillance system. There were 2,066
tuberculosis patients with other strain types notified in the West
Midlands between 2004 and 2008. Patient characteristics
identified as risk factors significant in a univariate analysis
(Table 1 and Table S1 for all epidemiological variables) were
residence in the West Midlands West Health Protection Unit Area
and then specifically residence in Wolverhampton, UK-born, and
Black Caribbean or White ethnic group. Significant negative
associations were identified with age not greater than 65 years old,
the Black African ethnic group or extra-pulmonary disease. No
significant association with resistance to any of the 1
st line
TB in the Midlands, UK
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identified. The significant variables were then included in a multi-
variate logistic regression which identified that being UK-born,
Black Caribbean ethnic group, .65 years old, and resident in
Wolverhampton, were significantly associated with the Mercian
strain (Table 1). Age .65 years old was a significantly negative
association with the Mercian strain. Therefore, age ,65 years old
is positively associated with the Mercian strain. There were no
statistically significant differences between patients with complete
data for each variable compared to those with missing data in both
this analysis and the following city-wide epidemiological investi-
gation.
City-wide epidemiological investigation in
Wolverhampton
The Mercian strain in Wolverhampton was significantly
associated with white UK-born patients who presented with
cavitations on chest X-ray and produced smear positive specimens
(Table 2 and Table S2 for all epidemiological variables). Patients
infected with the Mercian strain continued to experience weight
loss at 8 weeks after starting anti-tubercular chemotherapy. This
result was statistically significant (p,0.05). However, there was no
significant difference between treatment completion rates after 12
months.
Examination of the epidemiological factors revealed that cases
with the Mercian strain were more likely to have a previous history
of TB (9/35, 26%), and would have had significant previous
contact with a case of TB (24/35, 69%), and in particular patients
with the Mercian strain (13/35, 37%) (Table 2). Significant social
factors detected were evidence of excess alcohol intake and
cannabis use.
Discussion
We describe here the identification of the most prevalent M.
tuberculosis strain in the West Midlands, which we have termed the
Mercian strain. Concordant MIRU-VNTR and RFLP data from
six different geographical locations across the West Midlands
indicated that this strain is present in 3 major cities. Regional,
national, and global genotyping databases provided evidence that
this strain was restricted to the West Midlands region in England.
Regional data showed that this strain primarily infected UK-born,
Black Caribbean patients less than 65 years old.
The regional and Wolverhampton epidemiological investiga-
tions presented in this report identified significant associations for
the Mercian strain. However, they do not provide a full
explanation of why the Mercian strain is more prevalent compared
to other strains in the West Midlands. Drug and alcohol use were
identified as significant social factors in Wolverhampton. Alcohol
and drug use have been identified as significant associations in
previously reported tuberculosis outbreaks particularly in low-
incidence countries [19–22]. The cumulative number of cases and
continuing presence of the Mercian strain does not follow a typical
point-source outbreak pattern. The significant association with
younger age suggests that cases caused by the Mercian strain have
arisen as a result of recent transmission and not re-activation in
older patients. A possible transmission scenario is that after the
initial emergence of the Mercian strain there have been several
Figure 1. Incidence and cumulative total of the number of patients with the Mercian strain between 2004 and 2008.
doi:10.1371/journal.pone.0017930.g001
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social link. This has resulted in a large, complex social network
where transmission persists and the complete transmission
scenario is yet to be fully elucidated.
Both epidemiological investigations presented in this report
were retrospective and did not involve direct patient interviews.
The Mercian strain continues to be identified in the West
Midlands which means that enhanced epidemiological knowledge
could be obtained by prospectively investigating social links as
each new patient is diagnosed. Investigation of potential factors
which may cause a delay in diagnosis should be investigated as
well. The data presented by us identified the infected patient
population and also important common social factors. The exact
interaction of patient population and social factors should be
investigated further to identify and fully understand any
confounding factors.
It must be noted that the Wolverhampton epidemiological
investigation applied a detailed questionnaire that was only used in
this location. Of the three major cities in the West Midlands,
Wolverhampton had the highest proportion of the Mercian strain
(21%). Patients with the Mercian strain in Birmingham and
Coventry might differ in their use of drugs and alcohol. The results
from the Wolverhampton and region-wide analysis do not concord
exactly as different ethnic population groups were identified as at
highest risk: the White population in Wolverhampton but the
Black Caribbean group across the West Midlands.
Detection of this strain was only possible with the commence-
ment of universal prospective typing of all M. tuberculosis isolates in
the West and East Midlands. Only with universal prospective
DNA fingerprinting was the full extent of the Mercian strain in
the West Midlands fully characterized. Since the Mercian strain is
not a drug-resistant strain without associated phenotypic
Figure 2. Geographical mapping of cases with the Mercian strain in the West Midlands between 2004 and 2008. Primary Care Trusts
(PCTs) are regional NHS organizations in England that provide primary and community care. The city of Wolverhampton where the focused
epidemiological investigation was undertaken is highlighted in yellow. The postcode map was produced under license by Crown Copyright and
database right 2010. Ordnance Survey License 100016969/100022432.
doi:10.1371/journal.pone.0017930.g002
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complex strains, it would only have been possible to detect this
strain by universal prospective typing. The patient population in
which the Mercian strain has been identified is different to the
UK-wide situation for TB as the majority of patients diagnosed
each year in the UK are not born in the UK and originate from
the Indian Sub-Continent [9].
The 156 individual patients detected between 2004 and 2008,
make the Mercian strain one of the largest known community-
based clusters in the world. Previous major prevalent strains have
been identified in New York [23,24], Rotterdam [25], North
London [3], and Rio de Janeiro [26].
The most prevalent strain detected in the UK was an
isoniazid resistant strain in North London that was previously
reported in 70 patients [3], with a current total of over 300 cases
caused by this strain (Ibrahim Abubakar, Consultant Epidemi-
ologist & TB Section Head, Respiratory Diseases Department -
Tuberculosis Section, Health Protection Agency, personal
communication). Isoniazid resistance acted as a very useful
marker for detection of the strain. It was noted that without the
drug resistance marker only prospective typing of all isolates
would have detected this large, complex outbreak. This strain
was predominantly found in young White or Black Caribbean
UK-born adults with drug misuse as a common epidemiological
factor [3]. It is possible that patients in this population group
take longer to present clinically as TB may not be suspected
when initial symptoms develop or they might not seek medical
help soon after onset. Both factors aid strain transmission and
disease progression.
A strain was identified in 93/314 (30%) patients in Rio de
Janeiro that uniquely lacked a major region of genomic DNA
(.26.3 kb) which contained 10 genes including two potentially
immunogenic PPE genes [26,27]. The RD
Rio strain was associated
with a higher frequency of cavitary pulmonary disease [28]. The
major deletion identified in the RD
Rio strain has been hypothe-
sized as having a major impact on the virulence properties of the
RD
Rio strain. As the genomic content of the Mercian strain has
not been characterized, further work should determine whether
such a deletion or other similar major genomic variation has
altered the virulence of this strain leading to multiple transmission
events in and between three cities in the West Midlands.
Retrospective epidemiological studies have identified the earliest
isolate of the Mercian strain from 1995 in an archive strain
collection. This isolate was part of a cluster of 11 isoniazid resistant
strains identified between 1995 and 2000 which was reported
previously before the full regional extent of the Mercian strain was
known [2]. We have typed very few archived M. tuberculosis strains
from 1995 so the full extent of drug sensitive and drug resistant
Mercian strains 15 years ago has not yet been assessed. The cluster
of isoniazid resistant Mercian strains was present in one specific
location. From 1995–2000, there was no other investigated
instance of increased isoniazid resistance in the rest of the West
Midlands caused by the Mercian strain.
As the Mercian strain has been present since prospective DNA
fingerprinting was commenced in 2004 with a median of 30
isolates per year (range 27–37) and has represented a consistent
proportion of strains (Figure 1), it is likely that the Mercian strain
first emerged in the West Midlands well before 2004.
Figure 3. Results of RFLP analysis for isolates of the Mercian strain across the Midlands between 1995 and 2003. Each horizontal lane
is an example of an individual M. tuberculosis strain from each location and year. The molecular sizes of the digested DNA fragments of MT14323 are
shown in kilobases. The 8
th IS6110 fragment was identified in an isolate from Wolverhampton in 2003.
doi:10.1371/journal.pone.0017930.g003
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strain (n=124) and all other patients with strain typing data (n=2,066) in the West Midlands between 2004 and 2008.
No. patients Unadjusted Adjusted
Variable
Mercian
(n=124)
WT
(n=2,066) Odds Ratio 95% CI P Odds Ratio 95% CI p
Gender
Male 77 1,118 1.38 0.95–2.01 0.09 1.03 0.65–1.62 0.91
Age group (years)
0–14 4 45 1.27 0.45–3.59 0.69 0.35 0.07–1.63 0.18
15–44 92 1310 1.00 1.00 Reference
45–64 23 379 0.86 0.54–1.38 0.543 0.77 0.42–1.41 0.40
.65 5 330 0.22 0.09–0.53 ,0.01* 0.25 0.09–0.67 ,0.01*
HPU location in the West Midlands
East 47 1,126 1.00 1.00 Reference
North 10 206 1.16 0.58–2.34 0.67
West 67 727 2.21 1.50–3.24 ,0.01*
Local Authority
Wolverhampton 51 169 7.83 5.30–11.58 ,0.01* 9.29 5.69–15.19 ,0.01*
Place of birth
UK-born 100 546 18.03 10.22–31.81 ,0.01* 9.03 4.56–17.87 ,0.01*
Ethnic group
Black Caribbean 32 70 14.84 8.55–25.77 ,0.01* 5.68 2.96–10.91 ,0.01*
Black African 1 362 0.09 0.01–0.68 0.02 0.19 0.02–1.51 0.12
Indian Sub-Continent 33 1,102 1.00 1.00 Reference
Other 6 105 1.57 0.60–4.10 0.36 1.11 0.37–3.37 0.85
White 49 366 4.47 2.79–7.15 ,0.01* 1.75 0.95–3.22 0.07
Site of disease
Pulmonary sputum smear positive 59 655 1.00 1.00 Reference
Pulmonary sputum smear other 47 711 0.73 0.49–1.09 0.13 1.06 0.64–1.74 0.83
Extra pulmonary 18 685 0.29 0.17–0.50 ,0.01* 0.62 0.33–1.18 0.15
Clinical history of TB
Previous diagnosis of TB 10 85 0.60 0.30–1.20 0.15
Treatment
Patient admitted as in-patient 25 329 1.04 0.64–1.65 0.89
Treatment outcome at 12 months
Treatment completed 71 1,157 1.00 1.00 Reference
Died 3 108 0.45 0.14–1.46 0.19
Lost to follow up 4 72 0.91 0.32–2.55 0.85
Still on treatment 2 32 1.02 0.24–4.34 0.98
Treatment stopped 1 6 2.72 0.32–22.87 0.36
Transferred out 0 18 - - -
Not completed unknown 2 21 1.55 0.36–6.75 0.56
Unknown 2 13 2.51 0.56–11.32 0.23
Treatment outcome at 12 months
Successful 73 1,189 0.89 0.47–1.66 0.71
Drug Sensitivity Testing
Resistance to any 1
st line drug 5 93 0.89 0.35–2.22 0.79
MDR 1 15 1.10 0.14–8.43 0.92
*P-values were considered as statistically significant if #0.05. Significant unadjusted values were included in the multi-variate model.
The wild-type (WT) consisted of tuberculosis patients infected with M. tuberculosis strains other than the Mercian strain.
doi:10.1371/journal.pone.0017930.t001
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many countries TB control programs as it has been used to estimate
transmission in specific populations groups. The Netherlands have
undertaken universal prospective DNA fingerprinting of all M.
tuberculosis isolates since 1993 [29]. This enabled the identification of
transmission after migration in patients recently arrived in the
Netherlands as infections in 30% to 40% of Turkish, Moroccan,
and Somali patients could be attributed to recent transmission [29].
Secondly, it has also been shown in the Netherlands that
combining data obtained from nationwide tuberculosis contact
Table 2. Epidemiological data obtained from a city-wide investigation of patients with and without the Mercian strain in
Wolverhampton, UK between 2003 and 2006.
Unadjusted Adjusted
Variable
Mercian
(n=35)
WT
(n=47) Odds Ratio 95% CI p Odds Ratio 95% CI p
Patient gender
Female 18 20 1.42 0.54–3.77 0.43
Age group (years)
0–14 1 1 1.15 0.01–92.99 1.00
15–44 27 31 1.00 1.00 Reference
45–64 4 10 0.46 0.10–1.85 0.22
.65 3 5 0.69 0.10–3.95 0.72
Ethnic group
Indian Sub-Continent 11 23 1.00 1.00 Reference
Black African 0 6 - - -
Black Caribbean 9 6 3.06 0.75–13.46 0.07
Other 1 5 0.44 0.01–4.71 0.65
White 14 7 4.06 1.15–15.77 0.01*
Country of birth
UK-born 32 12 29.42 7.32–177.18 ,0.01* 9.68 2.00–46.78 ,0.01*
Epidemiological History
Previous contact with TB case 24 11 6.94 2.42–21.50 ,0.01* 3.40 0.92–12.59 0.07
Previous contact with Mercian strain 13 0 15.65 4.76–51.48 ,0.01*
Previous history of TB 9 3 4.97 1.11–31.13 0.01*
Clinical co-factors
Malignancy 1 0 10.41 0.20–547.59 0.43*
Diabetes 2 7 0.35 0.03–2.01 0.29
Social factors
Excess alcohol use 16 4 8.78 2.42–41.01 ,0.01* 6.26** 1.45–27.02 0.01
Cigarette smoking 6 3 2.99 0.58–19.96 0.12
Cannabis use 11 2 10.02 1.96–100.33 ,0.01*
Unemployed 21 23 1.56 0.59–4.18 0.32
Clinical presentation
Cavitary disease 22 12 4.83 1.74–14.24 ,0.01* 1.57 0.40–6.17 0.52
Pulmonary disease 31 34 2.93 0.79–13.64 0.07
Sputum specimen 25 24 2.37 0.87–6.84 0.06
Positive microscopy 22 17 2.94 1.10–8.19 0.02*
Treatment
Therapy non-adherence 7 3 3.61 0.75–23.42 0.06
Weight loss after initiation of treatment 8 0 12.99 3.00–56.28 ,0.01*
Completed treatment within 12 months 26 36 0.64 0.17–2.29 0.43
Drug Sensitivity Testing
Resistance to any 1
st line drug 0 1 - - -
MDR 0 0 - - -
*P-values were considered as statistically significant if #0.05.
**OR for excess alcohol use and cannabis use combined.
doi:10.1371/journal.pone.0017930.t002
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increased the number of defined epidemiological links. In
2,206 clustered cases, DNA fingerprinting increased the
number of epidemiologic links from 462 before DNA finger-
printing data was known to 1,002 epidemiologic established links
after cluster investigation involving a combination of molecular
and epidemiological data. DNA fingerprinting did not increase
the number of patients identified as contacts but cluster
monitoring did enable the identification of transmission events
not detected by contact investigations, the development and
evaluation of focused interventions and evaluation of regional
tuberculosis eradication programs [30]. A study in Maryland
showed that cluster investigation including DNA fingerprinting
analysis identified 43/113 (38%) of all detected patient links.
[31] .
A more recent study showed that DNA fingerprinting data
could be used to prospectively identify rapidly expanding clusters
before expansion actually occurred based on the properties of the
first two patients in a cluster. If the first two patients in a cluster
were identified within 3 months of each other, one or both were
,35 years old, and both patients resided in an urban area and
originated from Sub-Saharan Africa, there was a more than 5
times increased probability that this strain in an initial cluster of
two paired patients would be identified in 5 or more patients
within 2 years [32].
We describe here the identification of the most prevalent M.
tuberculosis strain in the West Midlands region of the UK,
with 156 isolates in a 5 year period between 2004 and 2008.
The Mercian strain has been significantly associated with UK-
born patients, appears to be geographically restricted to the
West Midlands region in the UK with evidence of ongoing
transmission.
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